Translate to...

Study: The immune effects of seclidemstat in aggressive ovarian cancer striking young women

Study: The immune effects of seclidemstat in aggressive ovarian cancer striking young women

A drug known as SP-2577 could help enable the body's own immune system to attack ovarian cancer, according to a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.